| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | -0.096 | 0.07 |
| mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | -0.062 | 0.08 |
| mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | 0.14 | 0.08 |
| mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | 0.062 | 0.08 |
| mRNA | MI-2 | CTRPv2 | pan-cancer | AAC | 0.09 | 0.09 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | 0.053 | 0.09 |
| mRNA | CHEMBL1222381 | CTRPv2 | pan-cancer | AAC | 0.053 | 0.1 |
| mRNA | indisulam | CTRPv2 | pan-cancer | AAC | -0.051 | 0.1 |
| mRNA | PF-184 | CTRPv2 | pan-cancer | AAC | 0.052 | 0.1 |
| mRNA | MST-312 | CTRPv2 | pan-cancer | AAC | -0.055 | 0.1 |